不同和共享的转录组签名与皮质缩相关,在遗传行为变异前退行前退行
Ting Shen1, Jacob W Vogel2, Vivianna M Van Deerlin3
1Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, 3700 Hamilton Walk, Richards 606B, Philadelphia, PA, 19104, USA.
Molecular neurodegeneration
|February 7, 2025
概括
这项研究揭示了皮质缩在行为变异前退行症 (bvFTD) 的独特遗传基础. 这些发现突出了影响大脑结构的共同和独特的分子通路,跨越了bvFTD的不同遗传形式.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 行为变异前变性 (bvFTD) 的特点是皮质缩,在基因子组中具有不同的模式.
- 显而易见的生物机制可能驱动这些异质缩模式.
研究的目的:
- 为了识别与bvFTD.中皮层厚度相关的共享和不一致的转录组签名.
- 探索bvFTD不同遗传形式的基因表达,突触密度和病理学之间的关系.
主要方法:
- 使用了一种整合成像转录学方法.
- 分析了皮层厚度,基因表达,神经递质受体/输送体密度以及与病理有关的基因.
- 对bvFTD中的C9orf72,GRN和MAPT遗传变异进行了功能丰富和相关性分析.
主要成果:
- 对于每种bvFTD的遗传形式,都确定了与皮层厚度相关的特定的转录基因特征.
- GRN-bvFTD基因与神经传递和昼夜活动相关;突触密度与皮质稀薄相关.
- 与TDP-43病理相关的共享基因在C9orf72-bvFTD和GRN-bvFTD中被发现,但不是MAPT-bvFTD.
结论:
- 综合性转录组学揭示了与bvFTD的区域脆弱性相关的共享和独特的基因.
- 这些发现提供了生物学解释,将基因表达与突触密度和病理联系起来.
- 这种方法揭示了基于遗传背景的bvFTD异质疾病分布的分子基础.
相关概念视频
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...